Adapted from BMJ 3 Feb 2024
No excess prostate cancer has been found in hypogonadal men who were treated with replacement testosterone over 20 months follow up.
A randomised trial of 5,000 men found no difference in genital problems between the treated group and the untreated group.
The incidences of prostate cancer, acute urinary retention, prostatic surgery, and drug treatment for urinary symptoms were all low and no different between the groups.
My comment: This should be reassuring for those men who need to take testosterone for sexual health reasons and also to correct their hormonal status, as testosterone deficiency can be one cause of type two diabetes in older men.
Diabetes Diet 